½ÃÀ庸°í¼­
»óǰÄÚµå
1736601

°ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå : À¯Çüº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Spatial Genomics Transcriptomics Market, By Type, By Technique, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 3¾ï 3,580¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 7¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â±îÁö CAGRÀº 13%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 3¾ï 3,580¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 13.00% 2032³â °¡Ä¡ ¿¹Ãø 7¾ï 9,000¸¸ ´Þ·¯
±×¸². °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Spatial Genomics Transcriptomics Market-IMG1

°ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐÀº À¯Àü¹°ÁúÀÇ °ø°£Àû ºÐÆ÷(Àü»çüÇÐ)¿Í »ýü Á¶Á÷ ³» ¹°¸®Àû ¹è°æÀ» µ¿½Ã¿¡ ºÐ¼®ÇÒ ¼ö ÀÖ´Â ÀÏ·ÃÀÇ Ã·´Ü ±â¼úÀ» ¸»ÇÕ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº À¯ÀüÀÚ°¡ Á¶Á÷ÀÇ Æ¯Á¤ ¼¼Æ÷¿Í ¿µ¿ª¿¡¼­ ¾î¶»°Ô ¹ßÇöµÇ´ÂÁö¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí, º¹ÀâÇÑ »ý¹°ÇÐÀû °úÁ¤°ú ±× °ø°£Àû ±¸¼º¿¡ ´ëÇÑ ´õ ±íÀº ÀÌÇØ¸¦ Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

À¯ÀüüÇÐ ¿¬±¸¿¡¼­ °ø°£Àû ÀλçÀÌÆ®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½Å¾à °³¹ß ¹× Á¤¹Ð ÀÇÇп¡ ´ëÇÑ ÀÀ¿ë, »ý¸í°úÇÐ ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ¼¼°è °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

±×·¯³ª ÷´Ü ±â¼ú ¹× ÀåºñÀÇ ³ôÀº ºñ¿ë, ƯÈ÷ ¼Ò±Ô¸ð ¿¬±¸ ÁÖüÀÇ Á¢±Ù¼ºÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇп¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ¼¼°è °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ °³¿ä, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä Æ¯Â¡, ½ÇÀû, Àü·« µî ÁÖ¿ä ¸Å°³º¯¼ö¸¦ ±âÁØÀ¸·Î Á¤¸®ÇÏ¿© ¼ö·ÏÇÏ¿´½À´Ï´Ù.
  • À̹ø Á¶»ç¿¡ Æ÷ÇÔµÈ ÁÖ¿ä ±â¾÷Àº 10x Genomics, NanoString Technologies, Inc., Bruker, Illumina, SciLifeLab, Novogene Co., Ltd., PerkinElmer Inc., Akoya Biosciences, Inc., S2 Genomics, Inc., Visiopharm, RareCyte, Horizon Discovery Ltd., IONpath µîÀÌ ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è °ø°£ À¯ÀüüÇÐ-Æ®·£½º½ºÅ©¸³Æ½ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • PORTERÀÇ ºÐ¼®
  • ÀμöÇÕº´ ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå, À¯Çüº°, 2020-2032³â

  • ±â±â
  • ¼ÒÇÁÆ®¿þ¾î¿Í Ç÷§Æû
  • ŰƮ¿Í ½Ã¾à
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå, ±â¼úº°, 2020-2032³â

  • °ø°£ Àü»çüÇÐ
  • °ø°£ À¯ÀüüÇÐ

Á¦7Àå ¼¼°èÀÇ °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå, ¿ëµµº°, 2020-2032³â

  • Drug Discovery & Development
  • ´Ü¹éÁúüÇаú À¯ÀüüÇÐ
  • Áúº´ ƯÁ¤
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Áø´Ü ½ÇÇè½Ç
  • Çмú¿¬±¸±â°ü
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ °ø°£ À¯ÀüüÇÐ ¹× Àü»çüÇÐ ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • 10x Genomics
  • NanoString Technologies, Inc.
  • Bruker
  • Illumina
  • SciLifeLab
  • Novogene Co., Ltd.
  • PerkinElmer Inc.
  • Akoya Biosciences, Inc.
  • S2 Genomics, Inc.
  • Visiopharm
  • RareCyte
  • Horizon Discovery Ltd.
  • IONpath

Á¦11Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
ksm 25.06.18

Spatial Genomics Transcriptomics Market size is estimated to be valued at USD 335.8 Mn in 2025 and is expected to reach USD 790 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 13% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 335.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.00% 2032 Value Projection: USD 790 Mn
Figure. Spatial Genomics Transcriptomics Market Share (%), By Region 2025
Spatial Genomics Transcriptomics Market - IMG1

Spatial genomics transcriptomics refers to a set of advanced techniques that enable the simultaneous analysis of both the spatial distribution of genetic material (transcriptomics) and the physical context within biological tissues. This approach provides insights into how genes are expressed within specific cells and regions of tissues, offering a deeper understanding of complex biological processes and their spatial organization.

Market Dynamics:

The growing demand for spatial insights in genomics research, applications in drug discovery and precision medicine, and increased funding for life sciences research are the major factors that are expected to drive the growth of the global spatial genomics transcriptomics market during the forecast period.

However, high costs of advanced technologies and equipment hinder accessibility, especially for smaller research entities, and this is expected to hamper the growth of the global spatial genomics transcriptomics market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the global spatial genomics transcriptomics market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global spatial genomics transcriptomics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include 10x Genomics, NanoString Technologies, Inc., Bruker, Illumina, SciLifeLab, Novogene Co., Ltd., PerkinElmer Inc., Akoya Biosciences, Inc., S2 Genomics, Inc., Visiopharm, RareCyte, Horizon Discovery Ltd., and IONpath
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global spatial genomics transcriptomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spatial genomics transcriptomics market.

Spatial Genomics Transcriptomics Market Detailed Segmentation:

  • By Type:
    • Instruments
    • Software & Platforms
    • Kits & Reagents
    • Others (Consumables & Accessories, etc.)
  • By Technique:
    • Spatial Transcriptomics
    • Spatial Genomics
  • By Application:
    • Drug Discover & Development
    • Proteomics & Genomics
    • Disease Identification
    • Others
  • By End User:
    • Pharmaceutical & Biotechnology Companies
    • Diagnostic Labs
    • Academic & Research Institutes
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • 10x Genomics
    • NanoString Technologies, Inc.
    • Bruker
    • Illumina
    • SciLifeLab
    • Novogene Co., Ltd.
    • PerkinElmer Inc.
    • Akoya Biosciences, Inc.
    • S2 Genomics, Inc.
    • Visiopharm
    • RareCyte
    • Horizon Discovery Ltd.
    • IONpath

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Spatial Genomics Transcriptomics Market, By Type
    • Spatial Genomics Transcriptomics Market, By Technique
    • Spatial Genomics Transcriptomics Market, By Application
    • Spatial Genomics Transcriptomics Market, By End User
    • Spatial Genomics Transcriptomics Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increased R&D spending by government organization
    • Growing Awareness about Personalized Medicine
    • Integration of Artificial Intelligence (AI) and Machine Learning (ML)
    • Technological Advancements in Spatial Genomics Transcriptomics
  • Restraints
  • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Spatial Genomics Transcriptomics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Spatial Genomics Transcriptomics Market, By Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Software & Platforms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Spatial Genomics Transcriptomics Market, By Technique, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Spatial Transcriptomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Spatial Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Spatial Genomics Transcriptomics Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Drug Discover & Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Proteomics & Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Disease Identification
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Spatial Genomics Transcriptomics Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Diagnostic Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

9. Global Spatial Genomics Transcriptomics Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

10. Competitive Landscape

  • 10x Genomics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NanoString Technologies, Inc.
  • Bruker
  • Illumina
  • SciLifeLab
  • Novogene Co., Ltd.
  • PerkinElmer Inc.
  • Akoya Biosciences, Inc.
  • S2 Genomics, Inc.
  • Visiopharm
  • RareCyte
  • Horizon Discovery Ltd.
  • IONpath
  • Analyst Views

11. Section

  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦